Amylyx Pharmaceuticals reported total assets of $264.56M and total liabilities of $25.40M for the quarter ended Jun 2026, up 36.0% year over year. This balance sheet covers 22 quarters of results from Mar 2021 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Balance Sheet | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accumulated Depreciation | 0.05M | 0.54M | 1.63M | 1.36M | 1.55M | |||||||||||||||||
| Assets | ||||||||||||||||||||||
| Current Assets | ||||||||||||||||||||||
| Cash & EquivalentsCash & Equiv. | 50.19M | 110.40M | 67.44M | 107.73M | 62.53M | 114.56M | 247.76M | 135.26M | 170.20M | 170.55M | 75.00M | 71.84M | 77.39M | 59.76M | 58.09M | 225.18M | 226.65M | 229.14M | 49.33M | |||
| Receivables - NetNet Receivables | 0.14M | 15.31M | 17.55M | 33.47M | 29.35M | 40.05M | 20.35M | 4.09M | 1.73M | 0.45M | 0.30M | 0.10M | 0.13M | 0.09M | ||||||||
| Receivables - OtherOther Receivables | 0.50M | 0.30M | 0.80M | 0.10M | 0.50M | 0.30M | 0.10M | 0.10M | 0.10M | 0.10M | 0.10M | 0.10M | 0.10M | 0.10M | 0.50M | |||||||
| Receivables | 0.14M | 15.81M | 17.86M | 34.27M | 29.45M | 40.55M | 20.65M | 4.19M | 1.83M | 0.55M | 0.40M | 0.20M | 0.23M | 0.19M | ||||||||
| Raw Materials | 0.41M | 7.15M | ||||||||||||||||||||
| Work In Process | 0.04M | 1.68M | ||||||||||||||||||||
| Finished Goods | 0.11M | 0.94M | ||||||||||||||||||||
| Inventory | 0.56M | 9.77M | 13.07M | 24.86M | 32.37M | 38.32M | ||||||||||||||||
| Prepaid Assets | 5.39M | 10.28M | 9.46M | 8.34M | 10.11M | 12.75M | 11.79M | 17.34M | 14.93M | 16.89M | 12.82M | 9.14M | 12.48M | 11.78M | 5.96M | 9.26M | 6.69M | 5.26M | 5.58M | |||
| Current Assets | 104.95M | 265.49M | 216.14M | 172.20M | 382.13M | 389.05M | 427.39M | 434.11M | 464.67M | 410.53M | 326.72M | 245.26M | 189.43M | 216.14M | 186.89M | 353.38M | 323.67M | 285.02M | 256.34M | |||
| Non-Current Assets | ||||||||||||||||||||||
| Property, Plant & Equipment (Net) | 0.47M | 1.29M | 1.86M | 2.12M | 2.61M | 2.56M | 2.64M | 2.76M | 2.69M | 2.46M | 1.47M | 1.25M | 0.96M | 0.82M | 0.45M | 0.40M | 0.31M | 0.21M | 0.20M | |||
| Long-Term Investments | 10.07M | 17.73M | 24.33M | 44.96M | ||||||||||||||||||
| Other Non-Current Assets | 3.44M | 0.46M | 0.46M | 0.72M | 0.72M | 0.72M | 0.72M | 0.72M | 0.72M | 0.72M | 0.72M | 1.44M | 1.45M | 1.45M | 1.45M | 2.50M | 2.50M | 2.50M | 2.50M | |||
| Non-Current Assets | 0.66M | 8.95M | 9.10M | 9.24M | 9.32M | 18.91M | 26.19M | 32.47M | 52.79M | 6.92M | 5.44M | 5.45M | 4.20M | 3.53M | 7.71M | 9.36M | 8.97M | 8.58M | 8.23M | |||
| Assets | 105.61M | 274.44M | 225.24M | 181.44M | 391.45M | 407.96M | 453.59M | 466.58M | 517.45M | 417.46M | 332.16M | 250.71M | 193.63M | 219.68M | 194.60M | 362.74M | 332.64M | 293.60M | 264.56M | |||
| Liabilities | ||||||||||||||||||||||
| Current Liabilities | ||||||||||||||||||||||
| Accounts Payables | 4.37M | 10.04M | 8.12M | 7.05M | 6.26M | 10.77M | 24.70M | 6.37M | 22.06M | 21.45M | 4.96M | 1.49M | 2.94M | 4.81M | 3.29M | 5.34M | 3.52M | 3.53M | 5.53M | |||
| Payables | 4.37M | 10.04M | 8.12M | 7.05M | 6.26M | 10.77M | 24.70M | 6.37M | 22.06M | 21.45M | 4.96M | 1.49M | 2.94M | 4.81M | 3.29M | 5.34M | 3.52M | 3.53M | 5.53M | |||
| Accumulated Expenses | 13.02M | 16.26M | 17.26M | 23.61M | 38.31M | 38.75M | 37.24M | 37.05M | 57.72M | 67.87M | 62.76M | 50.46M | 23.95M | 12.07M | 17.46M | 19.47M | 17.91M | 11.28M | 14.61M | |||
| Other Accumulated Expenses | 0.26M | 0.44M | 0.54M | 0.36M | 1.00M | |||||||||||||||||
| Current Leases | 1.41M | 1.79M | 1.99M | 2.04M | 2.09M | 2.15M | 2.20M | 2.26M | 2.31M | 2.37M | 1.97M | 1.52M | 1.05M | 0.67M | 0.98M | 1.26M | 1.16M | 1.01M | ||||
| Total Current Liabilities | 17.40M | 27.71M | 27.16M | 32.65M | 46.61M | 51.62M | 64.08M | 45.62M | 82.04M | 91.64M | 70.08M | 53.91M | 28.41M | 17.93M | 21.42M | 25.79M | 22.69M | 15.97M | 21.15M | |||
| Non-Current Liabilities | ||||||||||||||||||||||
| Non-Current Deffered Revenue | 0.04M | |||||||||||||||||||||
| Preferred Stock Liabilities | 134.79M | 239.35M | ||||||||||||||||||||
| Operating Leases | 5.79M | 5.29M | 4.77M | 4.24M | 3.69M | 3.14M | 2.57M | 1.98M | 1.38M | 0.77M | 5.10M | 0.46M | 0.33M | 5.30M | 4.95M | 4.70M | 4.48M | 4.25M | ||||
| Total Liabilities | 124.07M | 17.43M | 33.49M | 32.45M | 37.41M | 50.85M | 55.31M | 67.22M | 48.18M | 84.02M | 93.02M | 70.85M | 54.51M | 28.87M | 18.26M | 26.72M | 30.75M | 27.39M | 20.44M | 25.40M | ||
| Shareholder's Equity | ||||||||||||||||||||||
| Common Equity | -124.07M | -151.17M | 240.95M | 192.79M | 144.03M | 340.61M | 352.65M | 386.37M | 418.40M | 433.43M | 324.44M | 261.31M | 196.20M | 164.76M | 201.42M | 167.88M | 332.00M | 305.26M | 273.16M | 239.17M | ||
| Liabilities and Shareholders Equity | 105.61M | 274.44M | 225.24M | 181.44M | 391.45M | 407.96M | 453.59M | 466.58M | 517.45M | 417.46M | 332.16M | 250.71M | 193.63M | 219.68M | 194.60M | 362.74M | 332.64M | 293.60M | 264.56M | |||
| Retained Earnings | -155.84M | -203.70M | -257.80M | -311.52M | -354.22M | -352.65M | -330.57M | -309.68M | -304.95M | -423.74M | -496.44M | -569.15M | -606.69M | -642.60M | -684.04M | -718.43M | -751.43M | -792.71M | -836.13M | |||
| Treasury Shares | 14.50M | 37.11M |